Visionary Wealth Advisors’s NanoViricides NNVC Stock Holding History

Visionary Wealth Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.7K	Buy	+10,576	New	+$14.8K	﹤0.01%	688

Other funds holding NNVC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

TRUE Private Wealth Advisors Salem, Oregon $1.18B AUM 28.67% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

Asset Dedication LLC San Francisco, California $1.62B AUM 18.32% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Visionary Wealth Advisors's NNVC Position: Q3 2026 in Review

Visionary Wealth Advisors opened a new position in NanoViricides (NNVC) in Q3 2026: 10,576 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #688 among its holdings.

16 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.

Visionary Wealth Advisors held 10,576 shares of NanoViricides worth $13.7K as of Q3 2026.
NanoViricides was a new Visionary Wealth Advisors position in Q3 2026.
NanoViricides made up ﹤0.01% of Visionary Wealth Advisors's portfolio in Q3 2026, its #688 holding.
16 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.

Based on Visionary Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.